MVM-FGR

1

Review clinical trials related to MVM-FGR. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Cohort of Maternal Vascular Malperfusion-related FGR (CoMVMFGR)

Based on a precise diagnostic standard process, through a multicenter study, we will establish a cohort focusing on placenta-mediated fetal growth restriction (FGR). Long-term follow-up will be conducted to seek predictive indicators for short-term and long-term adverse outcomes of maternal vascular malperfusion-related FGR (MVM-FGR).

Participants needed: 500
Trial details
Age: 18-45Biological sex: FemaleType: ObservationalSponsor: Shanghai First Maternity and Infant HospitalUpdated: Jun 7, 2024Locations: 1Duration: 2 Years
Eligibility criteria

Early-onset FGR(<32 weeks) Estimated fetal weight (EFW) or abdominal circumferen... [+3]

Fetus with definitive genetic disorders related to FGR, fetus with confirmed int... [+1]